Heart Rate Variability in Patients with Coronary Artery Disease: Impact of Epidural Anesthesia

Yu.O. Svitlyk, Ya.M. Pidgirny, G.V. Svitlyk, O.V. Maksymov, Z.D. Lyba, M.O. Garbar


Objective. The paper describes the changes in the heart rate variability (HRV) under the influence of epidural anesthesia (EA) in patients with coronary artery disease (CAD) and in practically healthy individuals undergoing surgery for the inguinal hernia. Peculiarities of influence of bupivacaine and ropivacaine on the dynamics of changes of spectral and statistical indicators of a HRV in the perioperative period in the active and passive observation periods have been established.
Setting. Lviv Municipal Clinical Emergency Hospital.
Patients. Thirty seven males who were operated for the inguinal hernia with EA were examined. Group I (23 patients, mean age 56.61 ± 1.58 years) with CAD, stable angina (NYHA I–III) was randomly divided in to 2 subgroups — subgroup I (12 patients) — persons who had EA under local anesthetic (LA) bupivacaine (0.5%), and subgroup II (11 patients), in which LA was ropivacaine (0.75%). The group II included 14 healthy individuals (mean age 49.07 ± 2.07 years), who were randomly divided into 2 subgroups, in which EA was performed using bupivacaine (subgroup I, 7 patients) and ropivacaine (subgroup II, 7 persons).
The control group were healthy volunteers — 12 men aged 35 to 65 years (mean age 54.06 ± 3.74 years), in which the absence of CAD confirmed by exercise test (bicycle ergometer). Patients of the control group underwent echocardiography, Holter ECG monitoring with determination of statistical (time) and frequency (spectral) HRV, biochemical research.
Results. We have identified features of HRV in the active and passive observation periods depending on LA — bupivacaine and ropivacaine.
The active period of observation revealed more pronounced increasing in sympathetic influence on heart rhythm in patients who were exposed to ropivacaine. LF value was higher at 1.57 % in group I (subgroup II) and 32.42 % — in group II (subgroup II), compared with two subgroups of patients, which were administered bupivacaine. LF/HF ratio in subgroups of ropivacaine also was higher than the corresponding rates in subgroups of bupivacaine — at 3.39 % (group I) and 39.10 % (group II). Thus, patients of subgroups of ropivacaine had reduced sympathetic tone of vegetative nervous system less pronounced and had higher sympathotonia.
In all patients the growth activity of the parasympathetic nervous system was revealed, as described above. By analyzing this process based on the used LA, we have found that in patients of group I in the active period of monitoring HF-value in ropivacaineи subgroup was slightly (by 1.44 %) higher than the corresponding value in bupivacaine subgroup (p = 0.4567), and in the group II HF parameters in the subgroup of ropivacaine were on 9.71 % lower than the values in the subgroup of bupivacaine (p = 0.0587). These data indicate the ability of ropivacaine to inhibit vagal influences in patients without CAD and the lack of such in patients with CAD.
In subgroups of patients to which bupivacaine was administered, the highest in the daytime period was the value of VLF. So bupivacaine, compared with ropivacaine, more intensively increased humoral influences on HR.
We have not noted a significant difference between the levels of RMSSD and pNN50 in the application of both anesthetics in group II, but the value of SDNNi in ropivacaine subgroup was significantly lower (by 19.91 %) than in group of bupivacaine, confirming the ability of the ropivacaine to noticeably reduce vagal activity in persons without CAD.
Analyzing the dynamics in spectral parameters of HRV under a different LA in passive period of monitoring, significant differences in two subgroups in patients with CAD was not found.
At the same time in persons without CAD (group II) a significant decreasing in the values of HF and VLF with increa­sing value of LF/HF was observed, which confirms the ability of the ropivacaine to reduce activity of humoral effects on HR and depress the tone of the parasympathetic branch of HRV in this categories of patients.
Statistical parameters of HRV in passive period also indicated the less pronounced ability of ropivacaine to reduce the parasympathetic activity of vegetative nervous system in patients with CAD.
Simultaneously, we again had marked depressive effect of ropivacaine on parasympathetic tone in patients without CAD. In this group a tendency to the restoring of circadian rhythm of HR regulation was better (taking into account the dynamics of HRV during the day depending on the applied anesthetic).
Conclusions. Ropivacaine, compared with bupivacaine, less effectively reduces the sympathetic activity in all patients, mo­derate increases parasympathetic tone in patients with CAD and reduces it in persons without pathology of the cardiovascular system.
Considering the benefits of the ropivacaine on the autonomic balance of a heart activity in patients with CAD it can be regar­ded as the drug of choice for EA during surgical interventions for inguinal hernia in these patients.


epidural anesthesia; bupivacaine; ropivacaine; coronary artery disease; heart rate variability


Аксельрод А.С. Холтеровское мониторирование ЭКГ: возможности, трудности, ошибки / А.С. Аксельрод, П.Ш. Чомахидзе, А.Л. Сыркин. — Москва: МИА, 2007. — 186 с.

Амбулаторне холтерівське моніторування ЕКГ // Український кардіологічний журнал. — 2005. — Додаток 5. — С. 11-36.

Вариабельность сердечного ритма при непролиферативной диабетической ретинопатии / Цибадзе А.Д., Цуцкиридзе Л.Р., Курашвили Р.Б. [и др.] // Медицина неотложных состояний. — 2009. — № 3–4 (22–23). — С. 66-68.

Назаров Г.О. Мониторинг адекватности эпидуральной анестезии в сосудистой хирургии / Назаров Г.О., Тарабрин О.А., Владыка А.С. // Біль, знеболювання і інтенсивна терапія. — 2009. — № 3. — С. 50-55.

Налесный О.Н. Использование спектрального анализа вариабельности ритма сердца для оценки эффективности стресс-протекции комбинаций аналгоседации при адено-тонзиллотомиях у детей / Налесный О.Н., Снисарь В.И., Вагин С.В. // Біль, знеболювання і інтенсивна терапія. — 2007. — № 1. — С. 34-41.

Різник Л. Варіабельність серцевого ритму як індикатор вегетативного балансу та глибини наркозу. 20-річний досвід застосування в анестезіології. Варіабельність серцевого ритму та загальна анестезія. Чи на сьогодні реально можливо оцінити вегетативний баланс та глибину наркозу? / Л. Різник, К. Пшесмицкі // Біль, знеболювання і інтенсивна терапія. — 2005. — № 1. — С. 28-37.

Різник Л. Вплив фентанілу, тіопенталу та пропофолу на варіабельність серцевого ритму під час введення до загального наркозу / Л. Різник, К. Пшесмицкі // Біль, знеболювання і інтенсивна терапія. — 2006. — № 2. — С. 3-11.

Сорокіна О.Ю. Вплив засобів для регіонарного знеболювання на адаптаційні можливості функціонального стану серцево-судинної системи у хворих при урологічних операціях (експериментально-клінічне дослідження) [Текст] : дис... канд. мед. наук: 14.01.30 / Сорокіна Олена Юріївна ; Дніпропетровська держ. медична академія. — Д., 2001. — 199 арк. — арк. 179-199.

Deutschman C.S. Changes in heart rate variability under propofol anesthesia: a possible explanation for propofol-induced bradycardia / C.S. Deutschman, A.P. Harris, L.A. Fleisher // Anesthesia & Analgesia. — 1994. — № 79(2). — P. 373-377.

Differential effects of propofol and sevoflurane on heart rate variability / Kanaya N., Hirata N., Kurosawa S. [et al.] // Anaesthesiology. — 2003. — № 98(1). — P. 34-40.

Effects of propofol and fentanyl anesthesia on heart rate variability using two analytical methods / Hamada Y., Kameyama Y., Iizuka T. [et al.] // European Journal of Anaesthesiology. — 2004. — № 21, A-98. — P. 25.

Effects of thiopentone, etomidate and propofol on beat-to-beat cardiovascular signals in man / Scheffer G.J., Ten Voorde B.J., Karemaker J.M. [et al.] // Anaesthesia. — 1993. — № 48(10). — P. 849-855.

Heart rate variability during propofol anaesthesia / GalletlyD.C., Buckley D.H., Robinson B.J., Corfiatis T. // British Journal of Anaesthesia. — 1994. — № 72(2). — P. 219-220.

Palatini P. Heart rate: a strong predictor of mortality in subjects with coronary artery disease / Р. Palatini // European Heart Journal. — 2005. — № 26. — Р. 943-945.

DOI: https://doi.org/10.22141/2224-0586.3.50.2013.89614


  • There are currently no refbacks.

Copyright (c) 2017 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2017


 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru